TiLOOP®Bra Pocket

Matrice bioinerte titanizzata 3D per la chirurgia ricostruttiva prepettorale

In presenza di una neoformazione maligna della mammella e spesso anche quando c’è un forte rischio che si sviluppi un tumore vengono eseguiti interventi demolitivi di vario tipo, in rapporto allo sviluppo della malattia e alla strategia terapeutica prescelta.
La ricostruzione può essere immediata cioè eseguita durante lo stesso intervento demolitivo oppure può essere differita e cioè eseguita in un secondo tempo, a distanza di 6-9 mesi dopo il primo intervento.

Dall’esperienza maturata con decine di migliaia di interventi eseguiti con la rete TIloop BRA, siamo orgogliosi di presentarne l’evoluzione:

l’unica rete tridimensionale sintetica presagomata sul mercato approvata appositamente per la ricostruzione del seno dopo mastectomia con posizionamento pre-pettorale.

Il rivestimento in titanio aumenta notevolmente la biocompatibilità con i tessuti ed è proprio per questa sua caratteristica che da decenni è impiegato in altre branche della medicina.

Essa consente di posizionare la protesi mammaria immediatamente dopo la rimozione della massa tumorale evitando così il posizionamento dell’espansore temporaneo e successivamente, del secondo intervento.

La tiloop Bra Pocket accoglie l’impianto protesico rivestendolo integralmente, il muscolo non viene sollevato come avveniva con al tecnica dual-plane, non rimane altro che inserire la Pocket contenete la protesi e fissarla con dei punti di sutura al muscolo pettorale.

Il rivestimento brevettato in Titanio e la sua leggerezza garantiscono un’ottima biocompatibilità ed il massimo comfort per il paziente.

Per la scelta della misura più appropriata, richiedere la scheda tecnica ove si trovano maggiori informazioni in base alla proiezione e al volume dell’impianto protesico.

Codice	Descrizione	Pz./Conf.
60001383	TiLOOP® Bra Pocket small	1
60001385	TiLOOP® Bra Pocket medium	1
60001387	TiLOOP® Bra Pocket large	1

Scarica il video per poterlo consultare offline.

Contattaci per avere informazioni sul prodotto e ordinarlo

Compila il form

Chiamaci

T +39 02 87282900

Approfondimenti scientifici

Titanium-coated polypropylene mesh as innovative bioactive material in conservatives mastectomies and pre-pectoral breast reconstruction

2021 - Pietro Gentile, Marco Bernini, Lorenzo Orzalesi, Silvia Sordi, Icro Meattini, Francesca Lessi, Ashutosh Kothari e Claudio Calabrese

Background:

Breast reconstruction is rapidly evolving, thanks to the growing acceptance of synthetic meshes as innovative biomaterials. 276 patients undergoing mastectomy (total of 328 mastectomies) were analyzed in a retrospective observational study to evaluate the pre-pectoral immediate breast reconstruction (IBR) using an implant wrapped with Titanium-Coated Polypropylene Mesh (TCPM) vs. patients treated with tissue expander (TE), equally placed pre-pectorally (and wrapped with the same TCPM in 74.3% of the control group’ breasts).

Study results

Histological analysis showed a process of normal tissue repair with a complete mesh integration and normal healing. Conservative mastectomies with pre-pectoral IBR assisted by TCPM proved themselves oncologically safe, biologically integrated into native tissues, and highly accepted in terms of quality of life guaranteeing a more natural and aesthetic breast appearance.

Conclusion:

This retrospective observational study provided clinical and histological outcomes of the pre-pectoral IBR using an implant wrapped with TCPM vs. patients treated with TE, equally placed pre-pectorally.

All the histological analyses performed confirmed the TCPM mesh complete integration with the physiological aspects of healing: The Collagen 1 and 3 expressions did not differ, between TCPM and NO TCPM samples to confirm a process of healing overlapping to perfect device incorporation and normal healing.

Titanium-coated polypropylene mesh as innovative bioactive material in conservatives mastectomies and pre-pectoral breast reconstruction (7.71 Mb - pdf)

“To Pre or Not to Pre”: Introduction of a Prepectoral Breast Reconstruction Assessment Score to Help Surgeons Solving the Decision-Making Dilemma. Retrospective Results of a Multicenter Experience

2021 - Donato Casella, Juste Kaciulyte, Federico Lo Torto, Francesco L. R. Mori, Leonardo Barellini, Alfonso Fausto, Benedetta Fanelli, Manfredi Greco, Diego Ribuffo, Marco Marcasciano

Background:

Implant-based reconstruction is the most performed breast reconstruction, and both subpectoral and prepectoral approaches can lead to excellent results. Choosing the best procedure requires a thorough understanding of every single technique, and proper patient selection is critical to achieve surgical success, in particular when dealing with prepectoral breast reconstruction

Study results

352 patients were included; 112 of them underwent direct-to-implant immediate reconstruction, and 240 underwent the two-stage procedure with temporary tissue expander. In both cases, the implant was wrapped in a titanium-coated polypropylene TiLoop Bra. According to the Prepectoral Breast Reconstruction Assessment score, direct-to-implant reconstruction should have been performed 6.2 percent times less, leading to an increase of 1.4 percent in two-stage reconstruction and 4.8 percent in submuscular implant placement.

Conclusion:

To date, there is no validated system to guide surgeons in identifying the ideal patient for subcutaneous or retropectoral breast reconstruction and eventually whether she is a good candidate for direct-to-implant or two-stage reconstruction. The authors processed a simple risk-assessment score to objectively evaluate the patient’s risk factors, to standardize the decision-making process, and to identify the safest and most reliable breast reconstructive procedure

Tiloop Bra pocket Introduction of a Prepectoral Breast Reconstruction Assessment Score (592.42 Kb - pdf)

Mesh versus acellular dermal matrix in immediate implantbased breast reconstructione A prospective randomized trial

2016 - D. Gschwantler-Kaulich, P. Schrenk, V. Bjelic-Radisic, K. Unterrieder, C. Leser, A. Fink-Retter, M. Salama, C. Singer

Mesh versus acellular dermal matrix in immediate implantbased breast reconstructione A prospective randomized trial

This prospective, randomized, controlled, multicenter pilot study was performed at four Austrian breast cancer centers. Fifty patients with oncologic or prophylactic indication for mastectomy and IBBR were randomized to immediate IBBR with either an ADM(Protexa) or a titanized mesh (TiLOOPBra).

Da evidenziare sia il 30% di perdita di impianto nel gruppo di Protexa(contro il 7 % di tiloop),sia il miglior outcome estetico e grado di soddisfazione del gruppo Tiloop BRA.

TiLOOP V’s Protexa – Pilot study (613.97 Kb - pdf)